ADC Therapeutics (ADCT) Tax Provisions (2020 - 2025)
ADC Therapeutics (ADCT) posted quarterly Tax Provisions of $1.3 million for Q2 2025, up 435.9% year-on-year from $234000.0 in Q2 2024, and up 660.0% on a QoQ basis from $165000.0 in Q1 2025.
ADC Therapeutics (ADCT) Tax Provisions (2020 - 2025) Analysis & Trends
ADC Therapeutics (ADCT) has reported Tax Provisions for 6 consecutive years, with $1.3 million the latest figure, recorded in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 165,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 234,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -4.50 Mn |
| Mar 31, 2023 | -262,000.00 |
| Sep 30, 2022 | -711,000.00 |
| Jun 30, 2022 | -947,000.00 |
| Mar 31, 2022 | -1.17 Mn |
| Sep 30, 2021 | 145,000.00 |
| Jun 30, 2021 | 240,000.00 |
| Mar 31, 2021 | 107,000.00 |
| Sep 30, 2020 | -3,000.00 |
| Jun 30, 2020 | 104,000.00 |
| Mar 31, 2020 | 100,000.00 |